Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Cannabis Bioscience International Holdings (CBIH) Debt to Equity (2023 - 2025)

Cannabis Bioscience International Holdings' Debt to Equity history spans 3 years, with the latest figure at -$0.19 for Q4 2025.

  • For Q4 2025, Debt to Equity rose 16.75% year-over-year to -$0.19; the TTM value through Nov 2025 reached -$0.19, up 16.75%, while the annual FY2025 figure was -$0.23, 1.79% up from the prior year.
  • Debt to Equity for Q4 2025 was -$0.19 at Cannabis Bioscience International Holdings, up from -$0.21 in the prior quarter.
  • Across five years, Debt to Equity topped out at -$0.19 in Q4 2025 and bottomed at -$0.45 in Q2 2023.
  • The 3-year median for Debt to Equity is -$0.24 (2024), against an average of -$0.26.
  • The largest annual shift saw Debt to Equity soared 48.22% in 2024 before it dropped 0.18% in 2025.
  • A 3-year view of Debt to Equity shows it stood at -$0.31 in 2023, then rose by 25.1% to -$0.23 in 2024, then grew by 16.75% to -$0.19 in 2025.
  • Per Business Quant, the three most recent readings for CBIH's Debt to Equity are -$0.19 (Q4 2025), -$0.21 (Q3 2025), and -$0.23 (Q2 2025).